Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies Stephan Lobitz, Jacques Elion, Raffaella Colombatti, Elena Cela Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies is a Special Issue of the International Journal of Neonatal Screening. Sickle cell disease is one of the most common inherited blood disorders, with a huge impact on health care systems due to high morbidity and high mortality associated with the undiagnosed disease. Newborn screening helps to make the diagnosis early and to prevent fatal complications and diagnostic odysseys. This book gives an overview of diagnostic standards in newborn screening for sickle cell disease and examples of existing newborn screening programs. |
Common terms and phrases
activity analysis anemia associated authors babies benefit birth blood blood spots cause centers chromatography Clin clinical collection complications comprehensive countries CrossRef CrossRef][PubMed detection diagnosis Dijon disorders early effective evaluation experience families Figure follow France funding G6PD deficiency gene genetic glucose-6-phosphate Hematol hemoglobin hemoglobinopathies Hospital HPLC identified implementation improve increased India individual initial iron Italy laboratory levels Lille major mass spectrometry method mortality NBS programs neonatal screening newborn screening normal patients peak Pediatr performed phenotype pilot population positive prevalence prevention profiles public health PubMed recommended reduce reference regions reported samples screening for sickle screening program settings severe showed sickle cell disease significant standard Table testing thalassemia transfusion treatment United universal variants